Skip to main content
. 2016 Feb 2;7(21):30241–30249. doi: 10.18632/oncotarget.7148

Figure 3. Patient screening flow chart.

Figure 3

From 1,080 patients studied for KIT/PDGFRA mutations, 185 were KIT/PDGFRA wild-type and 146 were analyzed using targeted next-generation sequencing (NGS). There was insufficient genomic DNA or the library preparation failed for 39 patients.